Antiviral company Agenovir raises $10.6M

Agenovir Corp. (South San Francisco, Calif.) raised $10.6 million in a series A round led by VC firm Data Collective. Celgene Corp. (NASDAQ:CELG), Lightspeed Venture Partners and individual investors also participated.

The company is developing antiviral therapeutics to treat diseases linked to latent or persistent viral reservoirs. Agenovir is using CRISPR- Cas9 and other nucleases to disrupt or eliminate pathogenic intracellular viral DNA. ...